Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

Recruiting now

Conditions studied: Musculoskeletal System Disease

In brief

the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.

Key facts

Study ID

NCT04711551

Run by

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

People needed

2000

Starts

2018-05-30

Expected to finish

2030-05-30

Last updated by the study team

2025-02-17

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain;
• males and females;
• age >= 6 years.

You may not qualify if…

• age < 6 years
• patients not compliant with post-treatment monitoring procedures
• pregnancy

Where it is running

• Istituto Clinico San Siro (satellite center) — Milan, Italia, Italy (enrolling)
• IRCCS Ospedale Galeazzi-Sant'Ambrogio (coordinator) — Milan, Italy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.